Global Vascular Access Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Device Type;

Central Vascular Access Devices [Peripherally Inserted Central Catheters, Tunneled Catheters, Percutaneous Non-Tunneled Catheters, Implanted Ports, and Others] and Peripheral Vascular Access Devices [Peripheral Catheter, Midline Catheter, and Others]

By Application;

Administration of Drugs, Administration of Fluid & Nutrition, Diagnostics & Testing, and Others

By End User;

Hospitals/Clinics, Diagnostic Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn557500974 Published Date: June, 2025 Updated Date: July, 2025

Vascular Access Devices Market Overview

Vascular Access Devices Market (USD Million)

Vascular Access Devices Market was valued at USD 5,060.88 million in the year 2024. The size of this market is expected to increase to USD 8,020.94 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.


Global Vascular Access Devices Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.8 %
Market Size (2024)USD 5,060.88 Million
Market Size (2031)USD 8,020.94 Million
Market ConcentrationMedium
Report Pages394
5,060.88
2024
8,020.94
2031

Major Players

  • Becton Dickinson
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Abbott
  • Medtronic
  • Teleflex
  • AngioDynamics
  • B. Braun Melsungen AG
  • Smiths Medical
  • Terumo Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Vascular Access Devices Market

Fragmented - Highly competitive market without dominant players


The Vascular Access Devices Market is witnessing robust momentum, largely due to the growing need for efficient delivery of intravenous medications and fluids. These devices are essential for patient management across emergency, surgical, and long-term care settings. Over 65% of hospitalized individuals require some form of vascular access, reflecting its widespread clinical integration.

Shift Toward Minimally Invasive Techniques
There is a rising preference for minimally invasive vascular access techniques, driven by improved patient outcomes and procedural efficiency. Approximately 55% of vascular access insertions now use image-guided or less-invasive technologies. This shift not only enhances procedural success but also minimizes discomfort and recovery time.

Demand Fueled by Chronic Care Requirements
With the global burden of chronic illnesses on the rise, particularly in cancer and renal care, the demand for durable vascular access solutions has intensified. Over 60% of oncology infusions and nearly 45% of dialysis treatments now utilize these devices, affirming their role in long-term therapy delivery.

Clinical Training and Standardization Benefits
Enhanced awareness among healthcare professionals and the availability of structured training programs have improved the safe use of vascular access Devices. As a result, there has been a notable 30% drop in insertion-related complications, indicating the success of standardization and best practice implementation across clinical environments.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Device Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Vascular Access Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising prevalence of chronic diseases

        2. Increasing number of surgeries and hospitalizations

        3. Shift toward minimally invasive and ultrasound-guided techniques

        4. Expanding home infusion and ambulatory care models

        Restraints
        1. Risk of infections, such as CRBSIs and phlebitis

        2. Occurrence of thrombosis or catheter occlusion, impacting device performance

        3. Stringent regulatory requirements and lengthy approvals

        4. Shortage of skilled professionals to ensure safe

      2. Opportunities
        1. Surge in medical tourism and middle-class healthcare access

        2. Broader clinical applications in oncology, nephrology, critical care

        3. Expansion of home healthcare and ambulatory care services

      PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    2. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Vascular Access Devices Market, By Device Type, 2021 - 2031 (USD Million)
      1. Central Vascular Access Devices
        1. Peripherally Inserted Central Catheters
        2. Tunneled Catheters
        3. Percutaneous Non-Tunneled Catheters
        4. Implanted Ports
        5. Others
      2. Peripheral Vascular Access Devices
        1. Peripheral Catheter
        2. Midline Catheter
        3. Others
    2. Vascular Access Devices Market, By Application, 2021 - 2031 (USD Million)
      1. Administration of Drugs
      2. Administration of Fluid and Nutrition
      3. Diagnotics and Testing
      4. Others
    3. Vascular Access Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals/Clinics
      2. Diagnostic Centers
      3. Others
    4. Vascular Access Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Becton Dickinson
      2. Boston Scientific Corporation
      3. Edwards Lifesciences Corporation
      4. Abbott
      5. Medtronic
      6. Teleflex
      7. AngioDynamics
      8. B. Braun Melsungen AG
      9. Smiths Medical
      10. Terumo Corporation
  7. Analyst Views
  8. Future Outlook of the Market